Hongjie Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongjie Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Xinwu Ba
College of Chemistry and Materials Science, Hebei University, Baoding 071002, China
2 shared publications - Feng Liu
School of Basic Medical Sciences, Hebei University, Baoding 071002, Hebei, China
1 shared publication Hailei Zhang
College of Chemistry and Environmental Science, Hebei University, Baoding 071002, PR China
1 shared publication- Haisong Zhang
School of Clinical Medicine, Hebei University, Affiliated Hospital of Hebei University, Baoding, China
1 shared publication Haojia He
Laboratory of Sensory Neurobiology, School of Basic Medical Sciences, Hebei University, Baoding, 071002, China
1 shared publicationHongwei Gao
Laboratory of Sensory Neurobiology, School of Basic Medical Sciences, Hebei University, Baoding, 071002, China
1 shared publication
Latest Publications
- 15 November 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 357, 120857
Fuyuan Huoxue decoction ameliorates CFA-induced pain by modulating chemokine and IL-17 signaling pathways
- 15 November 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 357, 120857
Fuyuan Huoxue decoction ameliorates CFA-induced pain by modulating chemokine and IL-17 signaling pathways
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (4) , 2062-2067
Simultaneous Regulation of the Mechanical/Osteogenic Capacity of Brushite Calcium Phosphate Cement by Incorporating with Poly(ethylene glycol) Dicarboxylic Acid
Brushite calcium phosphate cement (brushite CPC) is a prospective bone repair material due to its ideal resorption rates in vivo. However, the undesirable mechanical property and bioactivity limited its availability in clinic application. To address this issue, incorporating polymeric additives has emerged as a viable solution. In this study, poly(ethylene glycol) dicarboxylic acid, PEG(COOH), was synthesized and employed as the polymeric additive. The setting behavior, anti-washout ability, mechanical property, degradation rate, and osteogenic capacity of brushite CPC were regulated by incorporating PEG(COOH). The incorporation of PEG(COOH) with carboxylic acid groups demonstrated a positive effect on both mechanical properties and osteogenic activity in bone repair. This study offers valuable insights and suggests a promising strategy for the development of materials in bone tissue engineering.
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (4) , 2062-2067
Simultaneous Regulation of the Mechanical/Osteogenic Capacity of Brushite Calcium Phosphate Cement by Incorporating with Poly(ethylene glycol) Dicarboxylic Acid
Brushite calcium phosphate cement (brushite CPC) is a prospective bone repair material due to its ideal resorption rates in vivo. However, the undesirable mechanical property and bioactivity limited its availability in clinic application. To address this issue, incorporating polymeric additives has emerged as a viable solution. In this study, poly(ethylene glycol) dicarboxylic acid, PEG(COOH), was synthesized and employed as the polymeric additive. The setting behavior, anti-washout ability, mechanical property, degradation rate, and osteogenic capacity of brushite CPC were regulated by incorporating PEG(COOH). The incorporation of PEG(COOH) with carboxylic acid groups demonstrated a positive effect on both mechanical properties and osteogenic activity in bone repair. This study offers valuable insights and suggests a promising strategy for the development of materials in bone tissue engineering.
- Open Access
- 25 July 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113466
Binding and inhibitory activities: A novel oral therapeutic agent for the treatment of hyperphosphataemia rats
- 25 July 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113466
Open AccessBinding and inhibitory activities: A novel oral therapeutic agent for the treatment of hyperphosphataemia rats